Why the study?
Does antihypertensive therapy, specifically ACE inhibitors and calcium channel blockers, improve outcomes and quality of life in elderly patients with hypertension?
Population
Elderly patients with hypertension (predominantly systolic hypertension)
Design
Review
Authors
Loading...
Supports hypertension control in elderly; leaves open randomized trials confirming ACE inhibitors and calcium channel blockers as first-line.
Does antihypertensive therapy, specifically ACE inhibitors and calcium channel blockers, improve outcomes and quality of life in elderly patients with hypertension?
ACE inhibitors and calcium channel blockers are recommended as first-line antihypertensive therapy in elderly patients due to their efficacy in reducing cardiovascular events and favorable side effect profiles.
Bursztyn et al. (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: